Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2021

Ottawa, ON /Business Wire/ January 19, 2022 / — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”) today reported its audited financial results for the year ended October 31, 2021. Unless otherwise noted, all figures are in Canadian currency.

The Corporation’s Audited Financial Statements for the year ended October 31, 2021, and the accompanying Management’s Discussion and Analysis have been filed on the System for Electronic Document Analysis and Retrieval and are available via its website (www.sedar.com). The financial information for the year ended October 31, 2021, should be read in conjunction with the Corporation’s Financial Statements as well as its Management’s Discussion and Analysis for the year ended October 31, 2021.

“2021 has been an important year for Avivagen as we continued to establish ourselves and our OxC- BetaTM product in a growing number of markets worldwide, with OxC-BetaTM now approved for sale in seven countries. The AB Vista-distribution agreement (US, Brazil and Thailand), increased product use by Philippines distributor UNAHCO, first commercial use of OxC-beta in sows (new product application), and becoming the cornerstone ingredient in a top selling premium brand of pet food in Taiwan highlight the progress achieved in 2021. Unfortunately, the ongoing Covid-19 pandemic with accompanying disruptions in the global supply chain and continued outbreaks of African Swine Fever (ASF) in Southeast Asia have led to an extremely challenging economic environment for all businesses, including many of Avivagen’s current customers. As a direct result of this, previously announced contracts with Melder and Transformadora have been pushed back. During this same period, potential new customers have completed numerous successful animal trials, with the expectation of new additional sales with our Mexican customers to follow.” says Kym Anthony, Chief Executive Officer.

Throughout this challenging period, Avivagen has continued to set a foundation for strong growth in 2022 and beyond. Initiatives include investment in a major toxicology study which is near completion, investment in additional inventory and further progress on obtaining our non-objection letter from the U.S. Food and Drug Administration (“FDA”), activities which we expect to contribute to future growth. Looking ahead, the Company expects to make further inroads in existing and new markets in Asia and the Americas in the coming year, progressing our relationships with customers in a number of key markets and continuing to grow many of the early-stage customer and partner relationships we successfully established in 2021 which are substantially additive as our customers have displayed growing and recurring revenue models.

Previously announced agreements with AB Vista and UNAHCO to supply OxC-BetaTM to feed producers in the United States, Brazil, Thailand and the Philippines are expected to result in recognized revenue beginning in the early part of 2022. The Company is also expecting to receive regulatory approval for the use of OxC-BetaTM in a number of large and important Asian feed production markets in the coming year.

The Company reported revenues of $1,295,991 ($1,177,857 in the year ending October 31, 2020) and a comprehensive loss of $(6,394,159) for the year ended October 31, 2021. This compares to a comprehensive loss in the year ending October 31, 2020 of $(4,751,287). As at October 31, 2021, the Company reported total assets of $3,477,774 (current assets of $3,216,022), total liabilities of $7,430,439, and shareholders’ deficit of ($3,952,665).

About Avivagen
Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

About OxC-beta™ Technology and OxC-beta™ Livestock
Avivagen’s OxC-beta™ technology is derived from Avivagen discoveries about β-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC- beta™ Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, and Malaysia.

Avivagen’s OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.

Forward Looking Statements

This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions “aim”, “anticipate”, “appear”, “believe”, “consider”, “could”, “estimate”, “expect”, “if”, “intend”, “goal”, “hope”, “likely”, “may”, “plan”, “possibly”, “potentially”, “pursue”, “seem”, “should”, “whether”, “will”, “would” and similar expressions. Statements set out in this news release relating to the future plans of Avivagen’s customers and the potential for additional and/or increased orders from such customers, anticipated growth in demand for Avivagen’s products, the anticipated date of fulfillment for the order described,  the possibility for OxC-beta™ Livestock to replace antibiotics in livestock feeds as well as fill a critical need for health support in certain livestock applications where antibiotics are precluded and the size of market opportunities are all forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the order described may not result in new orders for Avivagen’s products,  the customer plans may change due to many reasons, demand for Avivagen’s products may not continue to grow and could decline, Avivagen’s products may not gain market acceptance or regulatory approval in new jurisdictions or for new applications, including human applications, and may not be widely accepted as a replacement for antibiotics in livestock feeds, new market access may not occur in the timeline or manner expected by Avivagen, timing of fulfillment of the order may be delayed beyond current expectation for a number of reasons which would push fulfillment and recognition of revenues for this order into a future quarter or, in the worst case, cause the order to be terminated and the market opportunities may not be as large as Avivagen anticipates, in each case due to many factors, many of which are outside of Avivagen’s control.  Readers are referred to the risk factors associated with the business of Avivagen set out in Avivagen’s most recent management’s discussion and analysis of financial condition available at www.SEDAR.com. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information:

Avivagen Inc.
Drew Basek
Director of Investor Relations
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
Phone: 416-540-0733
E-mail: d.basek@avivagen.com

Kym Anthony
Chief Executive Officer
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
Head Office Phone: 613-949-8164

230 Responses

  3. May I just say what a comfort to uncover somebody who truly knows what theyre talking about on the internet. You actually know how to bring a problem to light and make it important. More and more people should look at this and understand this side of the story. Its surprising you arent more popular because you certainly have the gift.

  22. Im excited to discover this web site. I need to to thank you for ones time for this wonderful read!! I definitely savored every bit of it and I have you bookmarked to look at new information in your web site.

  23. Terrific article! This is the type of information that are supposed to be shared across the web.
    Shame on Google for no longer positioning this put up upper!
    Come on over and consult with my site . Thanks =)

  24. I believe that is one of the most significant information for me.
    And i’m glad studying your article. But want to statement on some normal things, The site style is
    perfect, the articles is in point of fact excellent : D.
    Excellent process, cheers

  26. I don’t need to tell you how important it is to optimize every step in your SEO pipeline. But unfortunately, it’s nearly impossible to cut out time or money when it comes to getting good content. At least that’s what I thought until I came across Article Forge… Built by a team of AI researchers from MIT, Carnegie Mellon, Harvard, Article Forge is an artificial intelligence (AI) powered content writer that uses deep learning models to write entire articles about any topic in less than 60 seconds. Their team trained AI models on millions of articles to teach Article Forge how to draw connections between topics so that each article it writes is relevant, interesting and useful. All their hard work means you just enter a few keywords and Article Forge will write a complete article from scratch making sure every thought flows naturally into the next, resulting in readable, high quality, and unique content. Put simply, this is a secret weapon for anyone who needs content. I get how impossible that sounds so you need to see how Article Forge writes a complete article in less than 60 seconds! order here.

  27. Hi, i read your blog occasionally and i own a similar one and i was just curious if you get
    a lot of spam remarks? If so how do you protect against it, any plugin or anything you
    can recommend? I get so much lately it’s driving
    me mad so any help is very much appreciated.

  28. Use artificial intelligence to cut turnaround time, extend your budget, and create more high-quality content that Google and readers will love. How It Works? WordAi is extremely fast and intuitive. Just enter your content, click rewrite, and in a matter of seconds, WordAi will rewrite an entire piece of content for you. WordAi comes up with different ways to express the same ideas by rewriting every sentence from scratch. This not only removes duplicate content, it also makes the rewritten content read completely naturally. Scale Your Business Make your entire content production process 10x more efficient. Use AI to create more high-quality, unique content that impresses clients and engages readers, all without having to put in more hours Register here and get a bonus.

  29. I was pretty pleased to discover this great site. I need to to thank you for your time for this particularly fantastic read!! I definitely appreciated every part of it and I have you book marked to see new stuff on your blog

  138. Everything is very open with a very clear clarification of the issues.
    It was definitely informative. Your site is very useful.
    Many thanks for sharing!

  139. Excellent facts. With thanks.how to write compare and contrast essay college board essay help me write a thesis statement

  178. An outstanding share! I’ve just forwarded this onto a co-worker who
    has been doing a little homework on this. And he actually bought
    me lunch due to the fact that I discovered it
    for him… lol. So let me reword this…. Thanks for the meal!!
    But yeah, thanx for spending the time to discuss this topic here on your blog.

  225. Now has Taiwanese to mingle with Malaysian people over radio.
    Features
    ● Listen to what’s happening in Radio;
    ● Listen to live radio programmes while browsing and socializing with your friends.
    ● Listen to Radio Online;
    ● Search your favourite Radio or channel via the search function.
    ● Stream Live Radio Channels;
    ● Daily Radio Listeners;
    ● Share and comment on your favourite radio;
    ● Set your location and will be accessible in your local area http://aerispartners.com/?URL=https://ludisdownty.weebly.com

    6add127376 kaibern

  226. The free version comes with all the features and tools you need in the way of a basic module. Join the community to access tons of new tools, such as the voice changer, card creator and the creature compendium, which can be used in combination. As always, the “Pro” version also includes all the features of the essential one.
    Jhon Kennaugh
    Editor in ChiefQ:

    how to load data from a txt file. C and NeHe Author https://google.ge/url?q=https://settbutacof.weebly.com

    6add127376 hetehiri

  227. Q:

    The Earth’s revolution around the Sun.

    The Earth is revolving around the Sun, but due to the mass of planets and asteroids that are moving with the Earth, are these actually making it so that the Sun’s gravity is acting on the Earth.
    I ask this because I was always under the assumption that because it is so massive the Sun would still exert an overwhelming gravity, causing the Earth to revolve around the Sun as it orbits it’s mass.
    So https://genrilocal.weebly.com

    6add127376 osbiigr

  228. AAIPS offers you to install an application called AVG Business on your PC.
    The following version has been found on the web: 3.1.3010.

    Users of the following programs are warned that the update to the newest version is available:

    123456

    Lightbox

    By updating to the newest version of AVG Business, you will receive the latest version of its parts, including the latest antimalware protection, recommended (and tested) in the https://maps.google.com.vc/url?sa=t&url=https://traltorsfinsthink.weebly.com

    6add127376 palagra

  229. AAIPS offers you to install an application called AVG Business on your PC.
    The following version has been found on the web: 3.1.3010.

    Users of the following programs are warned that the update to the newest version is available:

    123456

    Lightbox

    By updating to the newest version of AVG Business, you will receive the latest version of its parts, including the latest antimalware protection, recommended (and tested) in the https://maps.google.com.vc/url?sa=t&url=https://traltorsfinsthink.weebly.com

    6add127376 palagra

  230. In addition to this, the GUI is user friendly and the software is easy to figure out. However, due to the lack of countries supported, one must consider this application as a personal tool.
    Download here

    Elmap from Ronsii is a nice desktop broadcasting software for Mac OSX (Mac OSX 10.7 and above). The program allows users to build a website with streaming video, audio and text, and then stream it to various platforms. It also has a feature where users can add background music from their machine. Elmap is an easy-to-use broadcasting software, as it requires no technical knowledge. https://outracfepe.weebly.com

    6add127376 nirvzsyg

Leave a Reply

Your email address will not be published.